ClariVest Asset Management LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 1 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ClariVest Asset Management LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$1,289,000
-17.4%
24,422
-4.1%
0.04%
-2.3%
Q2 2020$1,560,000
+4.1%
25,460
-3.8%
0.04%
-4.4%
Q1 2020$1,498,000
-2.3%
26,473
-1.7%
0.04%
+28.6%
Q4 2019$1,533,000
-26.3%
26,933
-30.7%
0.04%
-25.5%
Q3 2019$2,079,000
-11.0%
38,857
-0.8%
0.05%
-11.3%
Q2 2019$2,337,000
-5.5%
39,157
-1.2%
0.05%
+6.0%
Q1 2019$2,472,000
-1.1%
39,650
-3.9%
0.05%
-7.4%
Q4 2018$2,500,000
+43.3%
41,265
+38.3%
0.05%
+74.2%
Q3 2018$1,745,000
+25.2%
29,832
-3.9%
0.03%
+29.2%
Q2 2018$1,394,000
-0.6%
31,046
-1.9%
0.02%0.0%
Q1 2018$1,403,000
+3.4%
31,653
+1.0%
0.02%
+4.3%
Q4 2017$1,357,000
+17.8%
31,353
+26.6%
0.02%
-14.8%
Q3 2017$1,152,000
-5.7%
24,773
+0.4%
0.03%
-10.0%
Q2 2017$1,222,000
-9.7%
24,673
-0.0%
0.03%
-11.8%
Q1 2017$1,353,000
+131.3%
24,682
+134.9%
0.03%
+112.5%
Q4 2016$585,000
+52.3%
10,507
+25.0%
0.02%
+45.5%
Q3 2016$384,000
+15.7%
8,407
+1.2%
0.01%
+10.0%
Q2 2016$332,000
+20.7%
8,307
+5.1%
0.01%
+25.0%
Q1 2016$275,000
-18.2%
7,907
+1.3%
0.01%
-11.1%
Q4 2015$336,000
+22.6%
7,807
+23.8%
0.01%
+12.5%
Q3 2015$274,000
-15.7%
6,3070.0%0.01%
-20.0%
Q2 2015$325,000
+34.3%
6,307
+1.6%
0.01%
+42.9%
Q1 2015$242,000
+1.3%
6,2070.0%0.01%
-12.5%
Q4 2014$239,000
+12.7%
6,207
+3.4%
0.01%0.0%
Q3 2014$212,0006,0000.01%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q4 2020
NameSharesValueWeighting ↓
UBS ASSET MANAGEMENT AMERICAS INC 2,300$203,550,0000.00%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders